“Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”, AJM, vol. 4, no. 2, pp. 50–54, Dec. 2021, doi: 10.48165/3e51d373.